Does injection-site erythema at week nine of a GLP-1 receptor agonist usually resolve without a dose change?

Question

For reference: injection-site erythema · nine · a GLP-1 receptor agonist. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this. I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer. Concretely, what should I do, and how would I know afterwards whether I did it right?

ben_akintola · Accepted Answer

Timing is the most useful diagnostic feature here and it is the one most often omitted from the question. Nausea incidence in the pivotal trials runs to roughly 40 to 45 per cent at the higher doses against 15 to 20 per cent on placebo, with vomiting at roughly 15 to 25 per cent against 5 to 8 per cent. Discontinuation specifically attributable to gastrointestinal adverse events was in the range of 4 to 7 per cent. Those are the numbers to hold in mind when someone describes their experience as unusual. Local reaction versus infection Feature Local reaction Sterile abscess Cellulitis Onset Hours to 2 days Days 1–4 days, progressive Warmth Absent or minimal Mild Marked Expansion Static or shrinking Slow Expanding Texture Firm, flat or raised Fluctuant Diffuse, indurated Systemic features None None Fever, malaise possible Action Observe, rotate site Clinical review Same-day clinical review On the detail: constipation outlasts the nausea because it has two causes and only one of them resolves. Gastric emptying accommodates over weeks; total intake, and therefore stool volume and the osmotic load reaching the colon, does not recover until intake does. This is why fibre alone can make it worse — you add bulk to a system that is short of water and short of motility. The prescribing information for each agent lists adverse reaction frequencies against placebo in a table, and reading that table is more informative than reading a hundred anecdotes, because it has a denominator. Write down in advance which symptoms mean stop and seek care. It is a short list and it is much easier to write when you are well.

tess_amankwah · Answer

Stated carefully, the mechanism explains the pattern. Delayed gastric emptying plus central appetite suppression produces early satiety, and early satiety plus a slowed transit produces exactly the symptom cluster people report.

Pancreatitis red flags worth memorising rather than looking up: severe, persistent epigastric pain radiating to the back, worse lying flat and better sitting forward, with nausea and vomiting that does not settle. That combination is an urgent assessment, not a dose adjustment. An isolated lipase elevation without that picture is common and usually not pancreatitis.

Fatigue attribution is a subtraction problem. Take out the energy deficit, the dehydration, the electrolyte shortfall and the poor sleep, and what remains attributable to the drug in the trials was modest — placebo-arm fatigue rates were within a few points of active-arm rates in most of the programme. The corollary is that the fixable causes are usually the actual causes.

A symptom diary with dates against dose steps answers most of these questions without anyone needing to guess.

shareimprove this answerflag

answeredtess_amankwah48k3825 Jul 2026

Does injection-site erythema at week nine of a GLP-1 receptor agonist usually resolve without a dose change?

gi-side-effects

titration

nausea

2 Answers

Local reaction versus infection

Sigma-Aldrich - Certified Reference Materials

Your answer

Browse

About

Feature	Local reaction	Sterile abscess	Cellulitis
Onset	Hours to 2 days	Days	1–4 days, progressive
Warmth	Absent or minimal	Mild	Marked
Expansion	Static or shrinking	Slow	Expanding
Texture	Firm, flat or raised	Fluctuant	Diffuse, indurated
Systemic features	None	None	Fever, malaise possible
Action	Observe, rotate site	Clinical review	Same-day clinical review